Stay updated on Pembrolizumab in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study record, indicating the page is inaccessible, with the surrounding header and footer visible while the main content area displays an error message.SummaryDifference20%

- Check37 days agoChange DetectedThe page now displays Revision: v3.6.6 instead of the previous v3.6.5, indicating a routine site update.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now displays revision v3.6.5, replacing the previous revision v3.6.4. This indicates a minor site update or patch to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates a small maintenance update with no changes to the study details or underlying content.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page's version label changed from v3.6.2 to v3.6.3, signaling a new revision of the page content. This update reflects a deployment of a newer page version and does not modify the core study information visible to users.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer site version.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.